Article

Design and feasibility of an Alzheimer’s disease blood test study in a diverse community-based population

2023-02-02

Abstract excerpt

<h4>ABSTRACT</h4> <h4>INTRODUCTION</h4> Alzheimer’s disease (AD) blood tests are likely to become increasingly important in clinical practice, but need to be evaluated in diverse groups before use in the general population. <h4>METHODS</h4> This study enrolled a community-based sample of older adults in the Saint Louis, Missouri, USA area. Participants completed a blood draw, AD8® dementia screening interview, Mon...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b7805916-9bdc-5039-b7f1-3f41505417ec
DOI: 10.1101/2023.01.31.23285249

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Design and feasibility of an Alzheimer’s disease blood test study in a diverse community-based populationDOI 10.1101/2023.01.31.23285249Read

Older US adults’ experiences with and views about cognitive screening and blood biomarker testing for Alzheimer's diseaseSemantic proximity Read

Equity and Transportability of Plasma ATN Phenotypes in a Population-Representative U.S. Aging CohortSemantic proximity Read

Dementia Risk Scores,<i>APOE,</i>and risk of Alzheimer disease: one size does not fit allSemantic proximity Read

Considerations regarding a diagnosis of Alzheimer’s Disease before dementia: a systematic reviewSemantic proximity Read

Alzheimer's disease plasma biomarkers and physical functioning in a diverse sample of adultsSemantic proximity Read

A FinnGen pilot clinical recall study for Alzheimer’s diseaseSemantic proximity Read

The Bio‐Hermes Study: Biomarker database developed to investigate blood‐based and digital biomarkers in community‐based, diverse populations clinically screened for Alzheimer's diseaseSemantic proximity Read

Protocol for the Next Generation brain health survey: an international survey of attitudes, understanding and exposure to brain health risk factors in young adultsSemantic proximity Read

Generalizability of trial criteria on amyloid-lowering therapy against Alzheimer’s disease to individuals with MCI or early AD in the general populationSemantic proximity Read

Assessing Cognitive Decline and Dementia Risk in Black and White Older Adults with Blood Biomarkers pTau217, GFAP, NfL, and Aβ ratioSemantic proximity Read

The Healthy Brain Initiative (HBI): A prospective cohort study protocolSemantic proximity Read

Discernment of cerebral amyloid and cognitive status using ultrasensitive blood biomarkers collected with a non-traditional anticoagulantSemantic proximity Read